§180.609. Fluoxastrobin; tolerances for residues.
40 C.F.R. § 180.609
General.
Tolerances are established for residues of fluoxastrobin, including its metabolites and degradates, in or on the commodities in the table below. Compliance with the tolerance levels specified below is to be determined by measuring only fluoxastrobin, (1E)-[2-[[6-(2-chlorophenoxy)-5-fluoro-4-pyrimidinyl]oxy]phenyl](5,6-dihydro-1,4,2-dioxazin-3-yl)methanone O-methyloxime and its Z isomer, (1Z)-[2-[[6-(2-chlorophenoxy)-5-fluoro-4-pyrimidinyl]oxy]phenyl](5,6-dihydro-1,4,2-dioxazin-3-yl)methanone O-methyloxime, calculated as the stoichiometric equivalent of fluoxastrobin.
Tolerances are established for residues of fluoxastrobin, including its metabolites and degradates, in or on the commodities in the table below. Compliance with the tolerance levels specified below is to be determined by measuring only fluoxastrobin, (1E)-[2-[[6-(2-chlorophenoxy)-5-fluoro-4-pyrimidinyl]oxy]phenyl](5,6-dihydro-1,4,2-dioxazin-3-yl)methanone O-methyloxime, its Z isomer, (1Z)-[2-[[6-(2-chlorophenoxy)-5-fluoro-4-pyrimidinyl]oxy]phenyl](5,6-dihydro-1,4,2-dioxazin-3-yl)methanone O-methyloxime, and its phenoxy-hydroxypyrimidine, 6-(2-chlorophenoxy)-5-fluoro-4-pyrimidinol, calculated as the stoichiometric equivalent of fluoxastrobin.
Section 18 emergency exemptions. [Reserved]
Tolerances with regional registrations. [Reserved]
Indirect or inadvertent residues. Tolerances are established for the indirect or inadvertent residues of fluoxastrobin, including its metabolites and degradates, in or on the commodities in the table below, when present therein as a result of the application of fluoxastrobin to the growing crops listed in paragraph (a)(1) of this section. Compliance with the tolerance levels specified below is to be determined by measuring only fluoxastrobin, (1E)-[2-[[6-(2-chlorophenoxy)-5-fluoro-4-pyrimidinyl]oxy]phenyl](5,6-dihydro-1,4,2-dioxazin-3-yl)methanone O-methyloxime and its Z isomer, (1Z)-[2-[[6-(2-chlorophenoxy)-5-fluoro-4-pyrimidinyl]oxy]phenyl](5,6-dihydro-1,4,2-dioxazin-3-yl)methanone O-methyloxime, calculated as the stoichiometric equivalent of fluoxastrobin.
Notes, amendments, and revision history
Amendments
[74 FR 67113, Dec. 18, 2009, as amended at 75 FR 60333, Sept. 30, 2010; 76 FR 50898, Aug. 17, 2011; 77 FR 26471, May 4, 2012; 77 FR 64915, Oct. 24, 2012; 79 FR 20105, Apr. 11, 2014; 79 FR 59119, Oct. 1, 2014; 82 FR 45735, Oct. 2, 2017; 84 FR 38143, Aug. 6, 2019]
Authority
Authority: 21 U.S.C. 321(q), 346a and 371.
Source
Source: 36 FR 22540, Nov. 25, 1971, unless otherwise noted.
Amendments
[74 FR 67113, Dec. 18, 2009, as amended at 75 FR 60333, Sept. 30, 2010; 76 FR 50898, Aug. 17, 2011; 77 FR 26471, May 4, 2012; 77 FR 64915, Oct. 24, 2012; 79 FR 20105, Apr. 11, 2014; 79 FR 59119, Oct. 1, 2014; 82 FR 45735, Oct. 2, 2017; 84 FR 38143, Aug. 6, 2019]